Controversies in revascularisation for stable coronary artery disease
Alexandra N Nowbar, Christopher Rajkumar, Rasha K Al-Lamee and Darrel P Francis
DOI: https://doi.org/10.7861/clinmed.2020-0922
Clin Med March 2021 Alexandra N Nowbar
ANational Heart and Lung Institute, London, UK and Hammersmith Hospital, London, UK
Roles: clinical research fellow
Christopher Rajkumar
ANational Heart and Lung Institute, London, UK and Hammersmith Hospital, London, UK
Roles: clinical research fellow
Rasha K Al-Lamee
BNational Heart and Lung Institute, London, UK and Hammersmith Hospital, London, UK
Roles: clinical senior lecturer
Darrel P Francis
CNational Heart and Lung Institute, London, UK and Hammersmith Hospital, London, UK
Roles: professor of cardiology
Article Tools
Controversies in revascularisation for stable coronary artery disease
Alexandra N Nowbar, Christopher Rajkumar, Rasha K Al-Lamee, Darrel P Francis
Clinical Medicine Mar 2021, 21 (2) 114-118; DOI: 10.7861/clinmed.2020-0922
Citation Manager Formats
Jump to section
- Article
- ABSTRACT
- Coronary artery disease
- Each extra vessel of coronary disease doubles mortality
- Ischaemia as a proxy for coronary disease
- Invasive ischaemia as an immediate catheter laboratory proxy for non-invasive ischaemia
- Unimpeachable evidence of therapeutic benefit from placebo-controlled trials
- Testing whether ischaemia ‘causes’ rather than ‘is associated with’ mortality
- Patients still often assume that elective revascularisation is life-saving
- Testing whether revascularisation relieves symptoms
- Left main stem disease
- Summary
- Key points
- Conflicts of interest
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.